Jul 26,2021

FARMALISTO AND SOCIALDIABETES SIGN A STRATEGIC ALLIANCE TO LAUNCH A COMPREHENSIVE DIABETES MANAGEMENT PROGRAM IN LATIN AMERICA

SocialDiabetes, the leading digital solution for diabetes management, and Farmalisto, the leading MedTech and pharmacy platform in Latin America, have announced a strategic alliance to launch a telemedicine platform aimed at transforming diabetes management and radically improving the lives of patients. In collaboration with SocialDiabetes, Farmalisto is poised to launch an innovative patient-centered integrated care program that, thanks to mobile technology, telemedicine, and universal connectivity of medical devices (IoT), allows for remote monitoring of patients, data management in real-time, and the analysis of patient behavioral patterns, providing personalized and effective healthcare. This innovative program will be launched in Colombia, Mexico, Chile, and Peru during the second half of 2021, and it is expected to expand throughout Latin America in the following year.

COLLABORATION PARTNERSHIP

#r&d

#telehealth

#rpm

View Analyst & Ambassador Comments
Go to original news
Apr 06,2022

Carevive Systems and Blue Spark Technologies Partner to Conduct Real-Time Remote Patient Monitoring Pilot

Carevive Systems announced today a partnership with Blue Spark Technologies, a leader and an innovator in wearable wireless medical device solutions. The study will integrate Carevive’s expertise in Patient Reported Outcomes (ePROs) data with Blue Spark’s TempTraq continuous wearable remote temperature monitoring solution to investigate how early fever detection can guide clinical decision-making for adult oncology patients who are at increased risk for infection. Patients in the study will report their symptoms through Carevive’s PROmpt® while wearing Blue Spark’s TempTraq®, a soft wearable patch that continuously, safely and comfortably monitors body temperature, allowing clinicians to also monitor real-time patient health data. The opportunity to learn from clinicians about these data value and patients about their reporting experience are key pilot goals.

COLLABORATION PARTNERSHIP

#connected device

#rpm

View Analyst & Ambassador Comments
Go to original news
Sep 24,2019

Tech startup Vizlitics is trying to democratize cancer care

At the HIMSS 2.0 Conference 2019, the CEO of Vizlitics Tarun Kumar shares the insights from the company's first product Cancer Insights in an interview.

PRODUCT

#mobile app

#rpm

View Analyst & Ambassador Comments
Go to original news
Mar 03,2023

The Drive to Adopt Digital Therapeutics: Where do we Stand?

As regulatory processes and reimbursements are refined, there needs to be a continued focus on how to maximize the benefits for patients and ensure DTx can play a role in improving outcomes. The key to this is integration into the clinical workflow. For a patient to get full benefits of the DTx, the data must be accessible to their provider and actionable within the workflow. It’s great if patients are using DTx solutions, but without bringing that data to their care providers – whether it’s a primary care doctor, specialist, physical or occupational therapist, psychologists or other healthcare practitioners — and in the context of other relevant clinical data from the EHR, the full potential of the impact DTx can have on patient care will not be realized.

#pdt

#telehealth

#rpm

View Analyst & Ambassador Comments
Go to original news
Mar 03,2023

Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study

Validated questionnaires are used to assess asthma control over the past 1–4 weeks from reporting. However, they do not adequately capture asthma control in patients with fluctuating symptoms. Using the Mobile Airways Sentinel Network for airway diseases (MASK-air) app, this study developed and validated an electronic daily asthma control score (e-DASTHMA). e-DASTHMA is a good tool for the daily assessment of asthma control. This tool can be used as an endpoint in clinical trials as well as in clinical practice to assess fluctuations in asthma control and guide treatment optimisation.

CLINICAL STUDY

#mobile app

#rpm

#rwe

View Analyst & Ambassador Comments
Go to original news
Mar 01,2023 TOP STORY

Careology and The Royal Marsden collaborate to improve mental health support for people living and dealing with cancer

Funded by The Royal Marsden Cancer Charity, the Careology app will provide access to a wide range of content specifically tailored for the needs of young people. It will include information on the topics identified by young people as most important to them including managing symptoms, fatigue, body image, food and nutrition and mental health support, specifically around dealing with anxiety.

COLLABORATION PARTNERSHIP

#institution

#mobile app

#rpm

View Analyst & Ambassador Comments
Go to original news
Feb 28,2023 TOP STORY

PAVmed Digital Health Subsidiary Veris Health's Veris Cancer Care Platform™ Goes Live

PAVmed Inc, a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, and its majority-owned digital health subsidiary Veris Health Inc., today announced that the Veris Cancer Care Platform™ (Veris CCP), designed to enhance personalized cancer care through remote patient monitoring (RPM), is now live following successful onboarding of the first cohort of cancer patients and their clinicians. Enrolled patients received a VerisBox™ and were then successfully trained to use its Veris-branded Bluetooth-enabled connected health care devices to transmit real-time physiologic data to the cloud-based Veris CCP clinician portal via an embedded cellular connection. The app is now available on the Apple App Store and Google Play.

PRODUCT

#rpm

#connected device

#mobile app

View Analyst & Ambassador Comments
Go to original news
Feb 02,2023

Mednow Launches New Virtual Diabetes Management Program in Partnership With Dexcom

Mednow Inc. announced today the launch of its enhanced Virtual Diabetes Management program, an end-to-end digital diabetes management solution, to enable convenient on-demand access to Dexcom G6 real-time continuous glucose monitoring supplies and personalized diabetes care services. The Mednow clinical team will utilize the Dexcom Clarity data platform, to integrate individual glucose patterns and trends into personalized coaching and care.

COLLABORATION PARTNERSHIP

#institution

#cgm

#rpm

View Analyst & Ambassador Comments
Go to original news
Feb 22,2023 TOP STORY

Dawn Health, Novartis partner to develop chronic condition management tools

Copenhagen-based digital health company Dawn Health announced a strategic partnership with pharma giant Novartis to develop a chronic condition management platform. Under the collaboration, Dawn and Novartis will build remote monitoring and management tools for chronic conditions where they see unmet need and concerns around disease progression, like multiple sclerosis, hypertension, cardiovascular disease and breast cancer. The platform will include patient mobile apps, symptom monitoring, digital biomarkers, clinical decision support services and virtual clinic offerings geared toward specific diseases and conditions.

COLLABORATION PARTNERSHIP

#r&d

#rpm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Feb 22,2023

Delve Health and UW Medicine Announce a Collaboration to Access Remote Data Capture for Diabetes Research

Delve Health and UW Medicine are announcing a collaboration to provide new insights into endemic Type 2 Diabetes research, through artificial intelligence and machine learning (i.e., AI/ML) and remote data capture via Delve Health’s digital healthcare platform. Delve Health’s Clinical StudyPal, a mobile and web-based platform that enables decentralized clinical trial research and remote patient monitoring, has been configured to capture patient data, 24-hours a day, through a wearable device (i.e., smart watch). NIH-funded Bridge2AI project called Artificial Intelligence Ready Equitable Atlas for Diabetes Insight (AI-READI; award project number 1OT2OD032644-01) will collect and release a flagship medical dataset for salutogenesis that will hopefully accelerate machine learning applications and generate novel hypotheses about Type 2 Diabetes Mellitus.

COLLABORATION PARTNERSHIP

#r&d

#rpm

View Analyst & Ambassador Comments
Go to original news
Subscribe to RPM